Other News To Note
Wednesday, February 23, 2011
Cytheris SA, of Paris, published data in Cell showing interleukin-7 (IL-7) was able to overcome many of the factors that thwart an effective immune response in diseases such as HIV infection and viral hepatitis. The study results also suggested how IL-7 therapy could be used to produce and expand specific T cells and promote a broad and durable immune-mediated antiviral response.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.